Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs for COPD
NCT04433104Phase 2Completed
- Sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology
- Start
- Jun 2020
- Primary completion
- Jul 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in chronic obstructive pulmonary disease (COPD), sponsored by Vinmec Research Institute of Stem Cell and Gene Technology. Started Jun 2020; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04433104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433104.